A detailed history of Barclays PLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Barclays PLC holds 376,900 shares of BSX stock, worth $34.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
376,900
Previous 4,075,236 90.75%
Holding current value
$34.1 Million
Previous $342 Million 90.75%
% of portfolio
0.01%
Previous 0.09%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$72.96 - $84.0 $6.06 Million - $6.98 Million
83,063 Added 2.08%
4,075,236 $342 Million
Q2 2024

Aug 14, 2024

SELL
$67.33 - $77.71 $3.66 Million - $4.22 Million
-54,345 Reduced 1.34%
3,992,173 $307 Million
Q1 2024

May 15, 2024

BUY
$57.6 - $68.62 $38.7 Million - $46.1 Million
671,795 Added 19.91%
4,046,518 $277 Million
Q4 2023

Feb 15, 2024

SELL
$48.64 - $57.81 $38.8 Million - $46.2 Million
-798,464 Reduced 19.13%
3,374,723 $195 Million
Q3 2023

Nov 07, 2023

BUY
$50.19 - $54.68 $20.8 Million - $22.6 Million
413,994 Added 11.01%
4,173,187 $220 Million
Q2 2023

Aug 03, 2023

BUY
$49.72 - $54.64 $122 Million - $135 Million
2,461,951 Added 189.78%
3,759,193 $203 Million
Q1 2023

May 04, 2023

SELL
$45.09 - $50.03 $40.7 Million - $45.1 Million
-901,779 Reduced 41.01%
1,297,242 $64.9 Million
Q4 2022

Feb 13, 2023

BUY
$39.56 - $47.22 $22.7 Million - $27.1 Million
573,278 Added 35.26%
2,199,021 $102 Million
Q3 2022

Nov 03, 2022

BUY
$36.71 - $109.66 $8.33 Million - $24.9 Million
227,034 Added 16.23%
1,625,743 $63 Million
Q2 2022

Aug 12, 2022

SELL
$35.24 - $47.1 $22.8 Million - $30.4 Million
-645,611 Reduced 31.58%
1,398,709 $52.1 Million
Q1 2022

May 16, 2022

SELL
$40.9 - $45.1 $24.8 Million - $27.4 Million
-607,129 Reduced 22.9%
2,044,320 $90.5 Million
Q4 2021

Feb 14, 2022

SELL
$38.07 - $44.87 $6.46 Million - $7.61 Million
-169,696 Reduced 6.02%
2,651,449 $113 Million
Q3 2021

Nov 09, 2021

BUY
$41.23 - $45.88 $29 Million - $32.3 Million
703,594 Added 33.23%
2,821,145 $122 Million
Q2 2021

Aug 13, 2021

BUY
$38.58 - $44.24 $20.2 Million - $23.2 Million
523,967 Added 32.88%
2,117,551 $90.5 Million
Q1 2021

May 13, 2021

BUY
$35.27 - $39.67 $425,673 - $478,777
12,069 Added 0.76%
1,593,584 $61.6 Million
Q4 2020

Feb 11, 2021

SELL
$33.15 - $41.97 $1.77 Million - $2.24 Million
-53,384 Reduced 3.27%
1,581,515 $56.9 Million
Q3 2020

Nov 12, 2020

BUY
$34.44 - $42.23 $21.9 Million - $26.8 Million
634,665 Added 63.45%
1,634,899 $62.5 Million
Q2 2020

Aug 12, 2020

SELL
$30.19 - $39.11 $58.6 Million - $75.9 Million
-1,940,660 Reduced 65.99%
1,000,234 $35.1 Million
Q1 2020

May 13, 2020

BUY
$25.83 - $45.71 $19 Million - $33.5 Million
733,795 Added 33.25%
2,940,894 $96 Million
Q4 2019

Feb 10, 2020

BUY
$37.87 - $45.37 $10.4 Million - $12.5 Million
275,882 Added 14.29%
2,207,099 $99.8 Million
Q3 2019

Nov 14, 2019

SELL
$40.31 - $43.45 $3.64 Million - $3.92 Million
-90,243 Reduced 4.46%
1,931,217 $78.6 Million
Q2 2019

Aug 14, 2019

BUY
$34.91 - $42.98 $17.1 Million - $21 Million
489,526 Added 31.95%
2,021,460 $86.9 Million
Q1 2019

May 15, 2019

BUY
$32.91 - $40.75 $5.72 Million - $7.09 Million
173,943 Added 12.81%
1,531,934 $58.8 Million
Q4 2018

Feb 14, 2019

SELL
$31.73 - $39.04 $7.89 Million - $9.71 Million
-248,633 Reduced 15.48%
1,357,991 $48 Million
Q3 2018

Nov 14, 2018

SELL
$32.83 - $38.63 $14.3 Million - $16.8 Million
-435,464 Reduced 21.32%
1,606,624 $61.9 Million
Q2 2018

Aug 14, 2018

SELL
$26.84 - $34.32 $3.27 Million - $4.19 Million
-121,996 Reduced 5.64%
2,042,088 $66.8 Million
Q1 2018

May 15, 2018

SELL
$25.2 - $28.54 $3.52 Million - $3.98 Million
-139,527 Reduced 6.06%
2,164,084 $59.1 Million
Q4 2017

Feb 14, 2018

BUY
$24.79 - $29.8 $35.4 Million - $42.6 Million
1,429,713 Added 163.6%
2,303,611 $57.1 Million
Q3 2017

Nov 14, 2017

BUY
$26.26 - $29.17 $22.9 Million - $25.5 Million
873,898
873,898 $25.5 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.